Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of oral estetrol for vasomotor symptoms in postmenopausal women
2015-004018-44Phase 2Completed
- Sponsor
- Donesta Bioscience B.V.
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of estetrol in vasomotor symptoms and vaginal atrophy (5 arms), sponsored by Donesta Bioscience B.V. Primary endpoint: Change in weekly frequency of moderate to severe vasomotor symptoms. Started Feb 2016; status: completed.
02
Drugs
estetrol
03
Conditions
vasomotor symptomsvaginal atrophy
Beyond the preview
Go deeper on 2015-004018-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004018-44.